Use of dietary supplements among women at high risk of hereditary breast and ovarian cancer (HBOC) tested for cancer susceptibility

Nutrition and Cancer

Volumn 54, Issue 2, 2006, Pages 157-165

  Alamian, Arsham ^a,b   Rouleau, Isabelle ^b   Simard, Jacques ^a,b   Dorval, Michel ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; FOLIC ACID; IRON; MAGNESIUM; MINERAL; MULTIVITAMIN; POTASSIUM; RETINOL; VITAMIN B GROUP; VITAMIN D; ZINC;

ADULT; AGED; ARTICLE; BRCA2 GENE; BREAST CANCER; CALCIUM INTAKE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; DIET SUPPLEMENTATION; DISTRESS SYNDROME; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEALTH BEHAVIOR; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MINERAL INTAKE; ONCOGENE; OVARY CANCER; PREVALENCE; VITAMIN INTAKE;

EID: 33748200098     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5402_1     Document Type: Article

References (43)

1. National Institutes of Health. National Center for Complementary and Alternative Medicine: What is complementary and alternative medicine (CAM)? Bethesda, MD. http://www.nccam.nih.gov/health/whatiscam/#1: Accessed Jan 10 2005.
2. 103rd Congress: Dietary Supplement Health and Education Act of 1994. Pub. Law 103-417. 108 Stat. 4325, 1994.
3. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, and Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287, 337-344, 2002.
4. Troppmann L, Johns T, and Gray-Donald K: Natural health product use in Canada. Can J Public Health 93, 426-430, 2002.
5. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, et al.: Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160, 339-349, 2004.
6. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, et al.: Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8, 477-485, 2002.
7. Sandler RS, Halabi S, Kaplan EB, Baron JA, Paskett E, et al.: Use of vitamins, minerals, and nutritional supplements by participants in a chemoprevention trial. Cancer 91, 1040-1045, 2001.
8. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, et al.: Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc 103, 323-328, 2003.
9. Morris KT, Johnson N, Homer L, and Walts D: A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179, 407-411, 2000.
10. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, et al.: Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94, 39-49, 2002.
11. Burnstein HJ, Gelber S, Guadagnoli E, and Weeks JC: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340, 1733-1759, 1999.
12. DiGianni LM, Kim HT, Emmons K, Gelman R, Kalkbrenner KJ, et al.: Complementary medicine use among women enrolled in a genetic testing program. Cancer Epidemiol Biomarkers Prev 12, 321-326, 2003.
13. Burke W, Daly M, Garber JE, Botkin J, Kahn MJE, et al.: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer genetics studies consortium. JAMA 277, 997-1003, 1997.
14. McIntosh A, Shaw C, Evans G, Turnbull N, Bahar N, et al.: Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. London: National Collaborating Centre for Primary Care/University of Sheffield, 2004.
15. Eisinger F, Bressac B, Castaigne D, Cottu PH, Lansac J, et al.: Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Cancer Bull 91, 219-237, 2004.
16. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, et al.: Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18, 2515-2521, 2000.
17. Kam IW, Dennehy CE, and Tsourounis C: Dietary supplement use among menopausal women attending a San Francisco health conference. Menopause 9, 72-78, 2002.
18. Harnack LJ, Rydell SA, and Stang J: Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. Mayo Clin Proc 76, 688-694, 2001.
19. Godard B and Simard J: INHERIT BRCAs. Les enjeux éthiques de l'identification d'une susceptibilité génétique au cancer du sein dans un contexte de recherche clinique intégrée. In: Molinari PA, ed. Les pratiques de recherche biomédicale visitées par la bioéthique. Paris: Dalloz, 2003, p 216.
20. American Society of Clinical Oncology: Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol 14, 1730-1740, 1996.
21. Rouleau I, Chiquette J, Plante M, Simard J, and Dorval M: Changes in health-related behaviours following brca1/2 genetic testing: the case of hormone replacement therapy. J Obstet Gynaecol Can 26, 1059-1066, 2004.
22. Horowitz M, Wilner N, and Alvarez W: Impact of Event Scale: a measure of subjective stress. Psychosom Med 41, 209-218, 1979.
23. Léger E, Freeston MH, Ladouceur R, Noreau L, and Tremblay L: Manifestations anxieuses chez les personnes ayant la sclérose en plaque ou une autre déficience physique. J Réadaptation Médicale 18, 4-8, 1998.
24. Horowitz M: Stress response syndromes and their treatment. In: Goldberger L, Breznitz, S., ed. Handbook of stress: Theoretical and clinical aspects. New York: Free Press, 1982, p 711-732.
25. Préville M, Boyer R, Potvin L, Perreault C, and Légaré G: La détresse psychologique: détermination de la fiabilité et la validité de la mesure utilisée dans l'Enquéte Santé Québec. Québec: Ministère de la Santé et des services sociaux, 1992.
26. Martin F, Sabourin S, and Gendreau P: Les dimensions de la détresse psychologique: analyse factorielle confirmatoire de type hiérarchique. Int J Psychol 24, 571-584, 1989.
27. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, et al.: BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 275, 1885-1892, 1996.
28. Santé Québec: Questionnaire sur les habitudes de vie et la santé 1998. Montréal: Ministère de la santé et des services sociaux, 1998.
29. Frank TS: Hereditary risk of breast and ovarian carcinoma: the role of the oncologist. Oncologist 3, 403-412, 1998.
30. American Society of Clinical Oncology: ASCO cancer genetics core curriculum. Alexandria, VA: American Society of Clinical Oncology, 1998.
31. Massey PB: Dietary supplements. Med Clin North Am 86, 127-147, 2002.
32. Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, et al.: An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 22, 671-677, 2004.
33. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, et al.: Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94, 1301-1311, 2002.
34. Michels KB, Holmberg L, Bergkvist L, Ljung H, Bruce A, et al.: Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women. Int J Cancer 91, 563-567, 2001.
35. Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, et al.: Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 91, 547-556, 1999.
36. Sato R, Helzlsouer KJ, Alberg AJ, Hoffman SC, Norkus EP, et al.: Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 11, 451-457, 2002.
37. Newman V, Rock CL, Faerber S, Flatt SW, Wright FA, et al.: Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet Assoc 98, 285-292, 1998.
38. Lyle BJ, Mares-Perlman JA, Klein BE, Klein R, and Greger JL: Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics. J Nutr 128, 2355-2362, 1998.
39. Adusumilli PS, Ben-Porat L, Pereira M, Roesler D, and Leitman IM: The prevalence and predictors of herbal medicine use in surgical patients. J Am Coll Surg 198, 583-590, 2004.
40. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, et al.: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280, 1569-1575, 1998.
41. Tsen LC, Segal S, Pothier M, and Bader AM: Alternative medicine use in presurgical patients. Anesthesiology 93, 148-151, 2000.
42. Lennox PH, Henderson CL: Herbal medicine use is frequent in ambulatory surgery patients in Vancouver Canada. Can J Anaesth 50, 21-25, 2003.
43. Scott GN, Elmer GW: Update on natural product-drug interactions. Am J Health Syst Pharm 59, 339-347, 2002.